US Neurology and Immunology Asset​/Indication Lead

Pursue Progress, Discover Extraordinary

Better is out there. Better medications, better outcomes, better science. But progress doesn't happen without people – people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen. So, let's be those people.

At Sanofi, we provide equal opportunities to all regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, ability or gender identity.

US Neurology and Immunology Asset/Indication Lead

Location:

Cambridge, MA

Sanofi's specialty care business unit focuses on immunology, neurology, oncology, rare blood disorders and rare diseases. Sanofi's ambition is to leverage science and innovation to improve people's lives and be the industry leader in immunology. Its approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. At Sanofi, we chase the miracles of science to improve people's lives.

We believe our cutting-edge science and manufacturing, fueled by data and digital technologies, have the potential to transform the practice of medicine, turning the impossible into possible for millions of people.

Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you'll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs.

You will work in the US Neurology and Immunology team of the Health Economics and Value Assessment (HEVA) department. The HEVA department gathers a wealth of expertise including experts in Health Economic and Outcomes Research (HEOR), Indirect Treatment Comparison & Network Meta Analysis (ITC/NMA), Modelling, Health Technology Assessment (HTA), epidemiology, biostatistics, and generation of real word evidence (RWE). We are one bold HEOR team leveraging innovative HEOR to transform patient care and access.

As HEOR experts, we lead the generation and dissemination of robust, business-relevant evidence to demonstrate value and drive access to medicines.

Main responsibilities:

This role will support tactical execution of US HEVA work for Neurology (Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyneuropathy) and Next Generation Immunology assets (Atopic Dermatitis, Celiac Disease, Inflammatory Bowel Disease, IgG4-related diseases, Nasal Polyps, etc.). The primary responsibilities are to:

• Design and execute Health Economic and Outcomes Research (HEOR) research in the forms of economic modeling, database analysis, observational research, systematic literature review, evidence synthesis, post hoc analysis of clinical trials, AMCP dossier development and other types of HEOR studies/deliverables to support value demonstration and differentiation in US market
• Drive measurable business impact through execution of HEVA tactics that directly support commercial objectives and market access goals compliantly and efficiently
• Execute comprehensive US HEVA tactics for the Neurology and Immunology portfolios, contributing to strategic planning and ensuring alignment with broader portfolio objectives
• Partner with U.S. Medical Affairs/Value & Access to ensure appropriate use of HEOR evidence in field communications and training
• Collaborate with Value & Access, US Medical Affairs, and Policy teams to deliver evidence that informs value frameworks, PDAB and ICER responses, value-based contracting strategies, etc.
• Set HEOR evidence generation priorities independently for assigned Neurology and Immunology indications and translate Target Value Propositions and US market access strategies into evidence hypotheses, requirements, and generation plans that address the unmet needs of payers, providers, and health systems

Internal Partnerships and Management Engagement

• Build and maintain strong relationships with cross-functional teams — including commercial, medical affairs, clinical development, and market access — to ensure pricing and access decisions are aligned with the demonstrable value of the Neurology and…